Fortamet
Identification
- Brand Name
- Fortamet
- Product Description
- Fortamet is a prescription biguanide available in multiple countries including the United States. It was first marketed in 2004. It is available in an Oral Tablet, extended release. It contains one active ingredient: Metformin, in its salt form Metformin hydrochloride. Metformin is a medication used with diet and exercise to control blood sugar in diabetes and is sometimes used to control high blood sugar in a disease called polycystic ovary syndrome (or PCOS).
- Ingredients
Drug Salt Metformin Metformin hydrochloride
Pharmacology
- Indications
- Adjunct therapy in management of Type 2 Diabetes Mellitus PrescriptionManagement of Polycystic Ovarian Syndrome (PCOS) Off LabelUsed as adjunct in combination to manage Type 2 Diabetes Mellitus in a regimen PrescriptionUsed as adjunct in combination to treat Type 2 Diabetes Mellitus in a regimen PrescriptionUsed in combination to manage Type 2 Diabetes Mellitus in a regimen Prescription
- Products
Dosage Strength Route Labeller Marketing Start Marketing End NDC Code Tablet, extended release 1000 mg/1 Oral Physicians Total Care, Inc. 2010-02-18 - US 54868-2894 Tablet, film coated, extended release 500 mg/1 Oral SHIONOGI INC. 2004-04-27 - US 59630-574 Tablet, film coated, extended release 1000 mg/1 Oral SHIONOGI INC. 2004-04-27 - US 59630-575 Tablet, extended release 500 mg/1 Oral Physicians Total Care, Inc. 2006-03-24 - US 54868-5558
Interactions
- Drug Interaction Search
- Warning: If no interactions are found between two drugs, it does not necessarily mean that no interactions exist. Always consult with a healthcare professional.This interaction checker is limited to 5 drugs at once, available for educational and information purposes only. It is not representative of the full commercial version, which integrates into your products. Learn more
- All Drug Interactions
- Show all
Drug Interaction Integrate drug-drug
interactions in your softwareAbacavir Metformin may decrease the excretion rate of Abacavir which could result in a higher serum level. Abemaciclib The excretion of Abemaciclib can be decreased when combined with Metformin. Acarbose The risk or severity of hypoglycemia can be increased when Acarbose is combined with Metformin. Acebutolol The therapeutic efficacy of Metformin can be increased when used in combination with Acebutolol. Aceclofenac Aceclofenac may decrease the excretion rate of Metformin which could result in a higher serum level. Acemetacin Acemetacin may decrease the excretion rate of Metformin which could result in a higher serum level. Acetazolamide The risk or severity of lactic acidosis can be increased when Acetazolamide is combined with Metformin. Acetohexamide The risk or severity of hypoglycemia can be increased when Metformin is combined with Acetohexamide. Acetyl sulfisoxazole The therapeutic efficacy of Metformin can be increased when used in combination with Acetyl sulfisoxazole. Acetylsalicylic acid The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Metformin. Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice.Learn more